Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the best emerging technology stocks to buy right now. The company develops precision genetic medicines using base editing, a next-generation approach that makes single-letter changes in DNA without cutting the double helix. This innovation reduces risks associated with traditional gene editing and offers higher accuracy. Beam’s platform could become the standard for safe and precise genetic corrections, placing it firmly among emerging biotech leaders. On Se ...